40 results
Keyword ipilimumab Remove keyword
-
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020 (updated)
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 October 2020
Virtual meeting, from 12/10/2020 to 15/10/2020, Last updated: 16/10/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2020
Virtual meeting, from 14/09/2020 to 17/09/2020, Last updated: 14/09/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/2018 -
List item
Paediatric Committee (PDCO): 23-26 January 2018
European Medicines Agency, London, UK, from 23/01/2018 to 26/01/2018, Last updated: 10/04/2018 -
List item
Paediatric Committee (PDCO): 12-14 August 2015
European Medicines Agency, London, UK, from 12/08/2015 to 14/08/2015, Last updated: 19/02/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2017
European Medicines Agency, London, UK, from 11/09/2017 to 14/09/2017, Last updated: 06/01/2014 -
List item
Paediatric Committee (PDCO): 21-24 February 2017
European Medicines Agency, London, UK, from 21/02/2017 to 24/02/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 17-19 July 2013
European Medicines Agency, London, UK, from 17/07/2013 to 19/07/2013, Last updated: 21/12/2010 -
List item
Paediatric Committee (PDCO): 13-16 December 2016
European Medicines Agency, London, UK, from 13/12/2016 to 16/12/2016, Last updated: 30/06/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 January 2016
European Medicines Agency, London, UK, from 25/01/2016 to 28/01/2016, Last updated: 25/01/2016 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 July 2018
European Medicines Agency, London, UK, from 23/07/2018 to 26/07/2018, Last updated: 06/01/2014EMEA/H/C/003985/WS1278/0042 Yervoy - ipilimumab - EMEA/H/C/002213/WS1278/0053 … -
List item
Paediatric Committee (PDCO): 16-18 July 2014
European Medicines Agency, London, UK, from 16/07/2014 to 18/07/2014, Last updated: 10/12/2010 -
List item
Paediatric Committee (PDCO): 20-23 February 2018
European Medicines Agency, London, UK, from 20/02/2018 to 23/02/2018, Last updated: 18/07/2014 -
List item
Paediatric Committee (PDCO): 8-11 November 2016
European Medicines Agency, London, UK, from 08/11/2016 to 11/11/2016, Last updated: 30/06/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-31 May 2018
European Medicines Agency, London, UK, from 28/05/2018 to 31/05/2018, Last updated: 06/01/2014 -
List item
Paediatric Committee (PDCO): 14-16 May 2012
European Medicines Agency, London, UK, from 14/05/2012 to 16/05/2012, Last updated: 25/08/2011activities EMA/PDCO/307494/2012 Page 3/6 Ipilimumab, from Bristol-Myers Squibb … -
List item
Paediatric Committee (PDCO): 18-20 April 2011
European Medicines Agency, London, UK, from 18/04/2011 to 20/04/2011, Last updated: 11/06/2010cardiovascular diseases; Ipilimumab, from Bristol-Myers Squibb … -
List item
Paediatric Committee (PDCO): 17-19 June 2015
European Medicines Agency, London, UK, from 17/06/2015 to 19/06/2015, Last updated: 20/07/2015 -
List item
Paediatric Committee (PDCO): 18-20 March 2015
European Medicines Agency, London, UK, from 18/03/2015 to 20/03/2015, Last updated: 19/02/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 6-9 November 2017
European Medicines Agency, London, UK, from 06/11/2017 to 09/11/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2016
European Medicines Agency, London, UK, from 22/02/2016 to 25/02/2016, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 October 2015
European Medicines Agency, London, UK, from 19/10/2015 to 22/10/2015, Last updated: 03/01/2014